﻿{"id":23436,"date":"2025-10-31T17:42:19","date_gmt":"2025-10-31T10:42:19","guid":{"rendered":"https:\/\/nhathuocngocanh.com\/bp\/?p=23436"},"modified":"2025-11-15T15:33:19","modified_gmt":"2025-11-15T08:33:19","slug":"febantel","status":"publish","type":"post","link":"https:\/\/nhathuocngocanh.com\/bp\/febantel\/","title":{"rendered":"Febantel"},"content":{"rendered":"<p>Edition: BP 2025 (Ph. Eur. 11.6 update)<\/p>\n<h2>DEFINITION<\/h2>\n<p>Dimethyl N,N\u2032-[[[2-(methoxyacetamido)-4-(phenylsulfanyl)phenyl]imino]methylene]dicarbamate.<\/p>\n<p><strong>Content<\/strong><\/p>\n<p>97.5 per cent to 102.0 per cent (dried substance).<\/p>\n<h2>CHARACTERS<\/h2>\n<h3>Appearance<\/h3>\n<p>White or almost white, crystalline powder.<\/p>\n<h3>Solubility<\/h3>\n<p>Practically insoluble in water, soluble in acetone, slightly soluble in anhydrous ethanol. It shows polymorphism (5.9).<\/p>\n<h2>IDENTIFICATION<\/h2>\n<p>Infrared absorption spectrophotometry (2.2.24).<\/p>\n<p><em>Comparison\u00a0<\/em> febantel CRS.<\/p>\n<p>If the spectra obtained in the solid state show differences, dissolve the substance to be examined and the reference substance separately in acetone R, evaporate to dryness and record new spectra using the residues.<\/p>\n<h2>TESTS<\/h2>\n<h3><strong>Related<\/strong> substances<\/h3>\n<p><em>Liquid<\/em> chromatography (2.2.29).<\/p>\n<p><em>Solvent mixture<\/em>\u00a0 acetonitrile R, tetrahydrofuran R (50:50 V\/V).<\/p>\n<p><em>Test solution (a)<\/em> Dissolve 0.100 g of the substance to be examined in the solvent mixture and dilute to 10.0 mL with the solvent mixture.<\/p>\n<p><em>Test solution (b)\u00a0<\/em> Dilute 5.0 mL of test solution (a) to 100.0 mL with the solvent mixture.<\/p>\n<p><em>Reference solution (a)<\/em> Dilute 1.0 mL of test solution (a) to 100.0 mL with the solvent mixture. Dilute 1.0 mL of this solution to 10.0 mL with the solvent mixture.<\/p>\n<p><em>Reference solution (b)<\/em> Dissolve 50.0 mg of febantel CRS in the solvent mixture and dilute to 10.0 mL with the solvent mixture. Dilute 5.0 mL of the solution to 50.0 mL with the solvent mixture.<\/p>\n<p><em>Reference solution (c)<\/em> Dissolve 5 mg of febantel for system suitability CRS (containing impurities A, B and C) in 1 mL of the solvent mixture.<\/p>\n<p><em>Column:<\/em><\/p>\n<p style=\"padding-left: 40px;\"><em>\u2014 size: l<\/em> = 0.15 m, \u00d8 = 4.0 mm;<\/p>\n<p style=\"padding-left: 40px;\"><em>\u2014 stationary phase:<\/em> spherical end-capped octadecylsilyl silica gel for chromatography R1 (5 \u00b5m).<\/p>\n<p><em>Mobile phase<\/em> Dissolve 6.8 g of potassium dihydrogen phosphate R in 1000 mL of water for chromatography R. Mix 350 mL of acetonitrile R with 650 mL of this solution.<\/p>\n<p><em>Flow rate\u00a0<\/em> 1.0 mL\/min.<\/p>\n<p><em>Detection<\/em>\u00a0 Spectrophotometer at 280 nm.<\/p>\n<p><em>Injection\u00a0<\/em> 10 \u00b5L of test solution (a) and reference solutions (a) and (c).<\/p>\n<p><em>Run time<\/em>\u00a0 1.5 times the retention time of febantel.<\/p>\n<p><em>Identification of impurities<\/em> Use the chromatogram supplied with febantel for system suitability CRS and the chromatogram obtained with reference solution (c) to identify the peaks due to impurities A, B and C.<\/p>\n<p><em>Relative retention<\/em> With reference to febantel (retention time = about 33 min): impurity A = about 0.16; impurity B = about 0.25; impurity C = about 0.34.<\/p>\n<p><em>System suitability\u00a0<\/em> Reference solution (c):<\/p>\n<p style=\"padding-left: 40px;\"><em>\u2014 resolution:<\/em> minimum 3.0 between the peaks due to impurities A and B; minimum 4.0 between the peaks due to impurities B and C.<\/p>\n<p><em>Limits:<\/em><\/p>\n<p style=\"padding-left: 40px;\"><em>\u2014 impurities A, B, C:<\/em> for each impurity, not more than the area of the principal peak in the chromatogram obtained with reference solution (a) (0.1 per cent);<\/p>\n<p style=\"padding-left: 40px;\"><em>\u2014 unspecified impurities:<\/em> for each impurity, not more than twice the area of the principal peak in the chromatogram obtained with reference solution (a) (0.20 per cent);<\/p>\n<p style=\"padding-left: 40px;\"><em>\u2014 total:<\/em> not more than 5 times the area of the principal peak in the chromatogram obtained with reference solution (a) (0.5 per cent);<\/p>\n<p style=\"padding-left: 40px;\"><em>\u2014 disregard limit<\/em>: 0.5 times the area of the principal peak in the chromatogram obtained with reference solution (a) (0.05 per cent).<\/p>\n<p><strong>Loss on drying (2.2.32)<\/strong><\/p>\n<p>Maximum 0.5 per cent, determined on 1.000 g by drying in an oven at 105 \u00b0C for 2 h.<\/p>\n<p><strong>Sulfated ash (2.4.14)<\/strong><\/p>\n<p>Maximum 0.1 per cent, determined on 1.0 g.<\/p>\n<h2>ASSAY<\/h2>\n<p>Liquid chromatography (2.2.29) as described in the test for related substances with the following modification.<\/p>\n<p><em>Injection\u00a0<\/em> Test solution (b) and reference solution (b).<\/p>\n<p>Calculate the percentage content of C<sub>20<\/sub>H<sub>22<\/sub>N<sub>4<\/sub>O<sub>6<\/sub>S taking into account the assigned content of febantel CRS.<\/p>\n<h2>IMPURITIES<\/h2>\n<p>Specified impurities\u00a0 A, B, C.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-23441\" src=\"https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/10\/Febantel-British-Pharmacopoeia-2025-1.jpg\" alt=\"Febantel\" width=\"1200\" height=\"650\" srcset=\"https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/10\/Febantel-British-Pharmacopoeia-2025-1.jpg 1200w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/10\/Febantel-British-Pharmacopoeia-2025-1-300x163.jpg 300w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/10\/Febantel-British-Pharmacopoeia-2025-1-1024x555.jpg 1024w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/10\/Febantel-British-Pharmacopoeia-2025-1-768x416.jpg 768w\" sizes=\"auto, (max-width: 1200px) 100vw, 1200px\" \/><\/p>\n<p>A. methyl [N-[2-(methoxyacetamido)-4-(phenylsulfanyl)phenyl]carbamimidoyl]carbamate,<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-23442\" src=\"https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/10\/Febantel-British-Pharmacopoeia-2025-2.jpg\" alt=\"Febantel\" width=\"1200\" height=\"650\" srcset=\"https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/10\/Febantel-British-Pharmacopoeia-2025-2.jpg 1200w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/10\/Febantel-British-Pharmacopoeia-2025-2-300x163.jpg 300w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/10\/Febantel-British-Pharmacopoeia-2025-2-1024x555.jpg 1024w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/10\/Febantel-British-Pharmacopoeia-2025-2-768x416.jpg 768w\" sizes=\"auto, (max-width: 1200px) 100vw, 1200px\" \/><\/p>\n<p>B. 2-(methoxymethyl)-5-(phenylsulfanyl)-1H-benzimidazole,<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-23443\" src=\"https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/10\/Febantel-British-Pharmacopoeia-2025-3.jpg\" alt=\"Febantel\" width=\"1200\" height=\"650\" srcset=\"https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/10\/Febantel-British-Pharmacopoeia-2025-3.jpg 1200w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/10\/Febantel-British-Pharmacopoeia-2025-3-300x163.jpg 300w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/10\/Febantel-British-Pharmacopoeia-2025-3-1024x555.jpg 1024w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/10\/Febantel-British-Pharmacopoeia-2025-3-768x416.jpg 768w\" sizes=\"auto, (max-width: 1200px) 100vw, 1200px\" \/><\/p>\n<p>C. methyl [5-(phenylsulfanyl)-1H-benzimidazol-2-yl]carbamate (fenbendazole).<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Edition: BP 2025 (Ph. Eur. 11.6 update) DEFINITION Dimethyl N,N\u2032-[[[2-(methoxyacetamido)-4-(phenylsulfanyl)phenyl]imino]methylene]dicarbamate. Content 97.5 per cent to 102.0 per cent (dried substance). CHARACTERS Appearance White or almost white, crystalline powder. Solubility Practically insoluble in water, soluble in acetone, slightly soluble in anhydrous ethanol. It shows polymorphism (5.9). IDENTIFICATION Infrared absorption spectrophotometry (2.2.24). Comparison\u00a0 febantel CRS. If the&#8230;<\/p>\n","protected":false},"author":5,"featured_media":23437,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[176],"tags":[],"class_list":["post-23436","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-british-pharmacopoeia-veterinary-2020"],"acf":[],"_links":{"self":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts\/23436","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/comments?post=23436"}],"version-history":[{"count":5,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts\/23436\/revisions"}],"predecessor-version":[{"id":23485,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts\/23436\/revisions\/23485"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/media\/23437"}],"wp:attachment":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/media?parent=23436"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/categories?post=23436"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/tags?post=23436"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}